Dementia News and Research

Latest Dementia News and Research

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Neurodegenerative disorders such as Alzheimer's and Parkinson's disease are associated with atypical proteins that form tangles in the brain, killing neurons.

29 Aug 2022

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

As populations around the globe age, dementia - often caused by Alzheimer's disease and related disorders - is a growing health issue for older adults worldwide.

26 Aug 2022

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Dr. Anaїs Rameau, an assistant professor of otolaryngology and an attending laryngologist at the Sean Parker Institute for the Voice at Weill Cornell Medicine, has been awarded a Paul B. Beeson Emerging Leaders Career Development Award in Aging by the National Institute on Aging, the American Federation for Aging Research and the John A. Hartford Foundation.

26 Aug 2022

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

26 Aug 2022

Brain stimulation improves memory function in older adults

Researchers evaluate the effectiveness of repetitive neuromodulation in improving the working memory and long-term memory of older adults.

25 Aug 2022

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

25 Aug 2022

Changes in brain connections occur very early in Alzheimer's disease

Although a lot is known about brain alterations in symptomatic Alzheimer's disease (AD), less is known about changes in the brain network early in the disease process.

24 Aug 2022

Study analyzes associations between BMI and dementia in older women and men

A substantial body of literature has analyzed the potential association between late-life body mass index (BMI) and dementia.

24 Aug 2022

Simple blood test can accurately detect Alzheimer's disease in people with Down syndrome

Around 80% of people with Down syndrome develop Alzheimer's disease, often when they are between 40 and 50 years old.

24 Aug 2022

Study provides evidence of a new form of dementia affecting WTC responders

A study that assessed the brains of 99 World Trade Center (WTC) responders by using diffusion tractography, a 3-D imaging technique, showed that WTC responders with cognitive impairment (CI), a possible sign of dementia, and post-traumatic stress disorder (PTSD), have a different presentation of the white matter in their brains compared to responders with CI without PTSD.

23 Aug 2022

UCL researchers identify multiple risk factors for a prematurely aging brain

By estimating people's brain age from MRI scans using machine learning, a team led by UCL researchers has identified multiple risk factors for a prematurely ageing brain.

23 Aug 2022

Risk trajectories of post-COVID neurological and psychiatric outcomes

Researchers examined the evolution of incidence or relative risk of neuropsychiatric diagnoses for two years in patients who had recovered from COVID-19.

22 Aug 2022

Alzheimer's disease disrupts visual memory by degrading cross-hemispheric cells

A new MIT study finds that Alzheimer's disease disrupts at least one form of visual memory by degrading a newly identified circuit that connects the vision processing centers of each brain hemisphere.

19 Aug 2022

Combination of new testing methods helps identify multiple dementia risk genes

A new UCLA-led study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder called progressive supranuclear palsy (PSP) by using a combination of new testing methods allowing for mass screening of genetic variants in a single experiment.

18 Aug 2022

Therapeutic target for several metabolic diseases may help fight Alzheimer’s disease

In the recent popular Korean TV series "The Light in Your Eyes," many viewers emphasized with the main character suffering from Alzheimer's disease.

18 Aug 2022

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

A recent article illustrated the derivation and validation of the QCOVID4 risk determination algorithm for predicting COVID-19 hospitalization and death risk in England.

18 Aug 2022

Expert panel identifies critical challenges in recruiting study participants

Unless cures are found, Alzheimer's dementia is projected to affect nearly 13 million Americans by 2050 - overwhelming families, caregivers and our healthcare system. Yet only one new therapeutic, aducanumab, has come to market in the past 20 years, and therapeutic progress remains hampered for several reasons: recruiting study participants in clinical trials for Alzheimer's is more challenging than other disease areas, the trials take longer to complete and they are more costly.

17 Aug 2022

UC San Diego receives $1.3 million grant to understand the role of misfolded tau proteins in dementia

Researchers at the University of California San Diego have received a $1.3 million grant from the W. M. Keck Foundation for a project that could help scientists better understand the role misfolded tau proteins play in causing neurodegenerative diseases like dementia, which may lead to more effective drug therapies.

16 Aug 2022

Neither cholesterol nor statins can explain an increased risk of developing dementia

Many patients stop taking medication for high cholesterol because they are afraid it may have negative side effects. But the observed association between risk of dementia and high cholesterol, may be caused by your lifestyle.

16 Aug 2022

Dementia News and Research

Latest Dementia News and Research

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Brain stimulation improves memory function in older adults

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

Changes in brain connections occur very early in Alzheimer's disease

Study analyzes associations between BMI and dementia in older women and men

Simple blood test can accurately detect Alzheimer's disease in people with Down syndrome

Study provides evidence of a new form of dementia affecting WTC responders

UCL researchers identify multiple risk factors for a prematurely aging brain

Risk trajectories of post-COVID neurological and psychiatric outcomes

Alzheimer's disease disrupts visual memory by degrading cross-hemispheric cells

Combination of new testing methods helps identify multiple dementia risk genes

Therapeutic target for several metabolic diseases may help fight Alzheimer’s disease

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

Expert panel identifies critical challenges in recruiting study participants

UC San Diego receives $1.3 million grant to understand the role of misfolded tau proteins in dementia

Neither cholesterol nor statins can explain an increased risk of developing dementia

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Dementia News and Research

Latest Dementia News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in